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ER-to-Golgi Carriers Arise through Direct
En Bloc Protrusion and Multistage Maturation
of Specialized ER Exit Domains
unclear how these structures arise from the ER, how they
discharge cargo into the Golgi complex, and whether
the ER-to-Golgi carriers (later referred to as “carriers”)
represent transient transport intermediates that are con-
stantly forming from the ER and being consumed at the
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microscopy and tomography. We found that saccular vesicles. Both then evolve into translocating carriers
carriers containing either the large supramolecular through multiple maturation stages.
cargo procollagen or the small diffusible cargo protein
VSVG arise through cargo concentration and direct Results
en bloc protrusion of specialized ER domains in the
vicinity of COPII-coated exit sites. This formation pro- The formation of ER-to-Golgi carriers was analyzed us-
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al., 2001).Traffic between the ER and the Golgi in animal cells is
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Figure 1. Structure of PC-Containing Car-
riers
HFs (A, D, and E) and CEFs (B and C) were
subjected to hydroxylation blocks (HFs, 1%
calf serum in the absence of ascorbic acid at
40C for 3 hr; CEFs, 0.3 mM dipyridyl [see
Bonfanti et al., 1998] for 1 hr). Cells were fixed
at 0 (A and C–E), 4 (B), or 10 min (F–M) after
hydroxylation block release (HFs, 32C  50
M ascorbic acid; CEFs, after dipyridyl wash-
out) and prepared for IF or IEM. Three-dimen-
sional reconstruction and surface rendering
of PC containers was performed on deline-
ated serial sections.
(A) ER-like pattern of the PC labeling before
the release of the block (0 min). No colocaliza-
tion of PC (green) is seen with Sec31 (red).
PC colocalizes with calreticulin (not shown).
(B) Four minutes after the release of the trans-
port block, PC is in spots (green) that do not
colocalize with Sec31 (red).
(C) Diffuse distribution of PC (enhanced gold
particles, arrow) through ER cisternae.
(D) Distribution of Sec31 (enhanced gold par-
ticles, arrows) at an ERES and at ER cister-
nae (asterisks).
(E) PC (DAB precipitate) is abundant in dis-
tended ER cisternae, whereas an ERES
(arrows) is devoid of PC.
(F) Ten minutes after the block release, folded
PC (green) appears as spots offset from
Sec31-positive spots (red).
(G) PC (thin arrows) at the EM level is visible
as gold aggregates in distended ER domains
near ERESs (thick arrows). The PC staining
does not have the diffuse ER appearance
seen in (C).
(H) The type II carrier. The PC container is
connected (thick arrow) with the ER (arrow-
head). Profiles of the ERES (thin arrow) do
not contain PC.
(I) Three-dimensional view of the type II car-
rier shown in (C). The PC-positive container
is in red, and the ER is in white. The PC-
negative container is in yellow.
(J and K) Type III carrier. Serial sections of
the tangential tubule (thin arrow) containing
a varicosity with PC (DAB precipitate; thick
arrow).
(L) Type IV carrier. Two saccules are filled with PC (thick arrows), whereas profiles of an ERES (thin arrow) do not contain PC.
(M) Three-dimensional view of the type IV carrier shown in (H). The ERES is in yellow, the ER in green, and the PC-positive container is in red.
The scale bars represent 5 m (A), 2 m (B and F), 100 nm (C–E and L), 200 nm (G and H), and 350 nm (J and K).
see legend to Figure 1). This block was then released, the COPII-labeled ER exit sites (ERESs; Figure 1B). The
ERESs (using antibodies against either Sec23 or Sec31,and the cells were examined after 0, 4, and 10 min. At
time 0, by immunofluorescence (IF), unfolded PC exhib- subunits of the COPII coat) appeared as bright roundish
spots of an apparent diameter of 0.5–1.0 m that wereited the predictable diffuse, reticular distribution (Figure
1A) and could not be detected by the LF68 antibody scattered throughout the cell and numbered between
100 and 200 (Figures 1A and 1B). In thin EM sections,against folded PC (not shown). In corresponding EM
images, PC was homogeneously distributed throughout the ERESs were seen as small clusters of three to ten
round-to-ovoid profiles that labeled for COPII (Figurethe distended cisternae of the ER (Figure 1C). Four min-
utes after the release of the folding block, PC began to 1D), and PC appeared concentrated in distended do-
mains of the ER of 600–800 nm in diameter that wereconcentrate in dots of varying brightness (typically 3-
fold higher than that of the surrounding ER) that were located close to (within 0.5 m), and continuous with,
ERESs attached to the ER cisternae (Figure 1E).scattered throughout the cytoplasm. They were detect-
able by the antibody against folded PC (not shown), Ten minutes after the release of the block, a subset
of PC carriers had left the ERESs and reached the Golgi;indicating that PC folding was taking place. These dots
were very close to, but usually not overlapping with, however, other PC carriers were still scattered in the
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cell periphery (not shown). In contrast, the ERESs had signal concentrated exclusively at the ERESs, in parallel
not changed in number and distribution. At the EM level, with VSVG (Figure 2J). A second difference was that the
the PC-positive structures (carriers) could be subdivided forming VSVG carriers were positive for COPII (Figures
into four categories (see below for a schematic repre- 2E, 2F, and 2L; for immuno-EM, see below; at variance
sentation). Type I: distended domains of the ER located with PC-containing carriers; see above), possibly again
close (from a few nm to 0.5 m) to an ERES (Figures 1F as a consequence of binding between VSVG and COPII.
and 1G). These structures were very similar to those Third, while PC was never detected in ERESs, VSVG
seen at 4 min (above) and are therefore likely to be was usually found to fill a portion of the adjacent ERES
containers seen just in the process of appearing from the (Figures 3A and 3B).
ER. Type II: flattened and elongated (300 nm) saccules In these VSVG carriers, we also examined the localiza-
protruding from, but still in continuity through tubules tion of COPI. COPI was found in types II and IV carriers
with, the ER (Figures 1H and 1I). The saccules had aver- (see below). In detail, in type II carriers, COPI was absent
age dimensions of 350 by 150 nm (i.e., large enough to from the main saccular body and was concentrated at
contain 300 nm long PC trimers) and were still in the the isthmus of the protruding containers (Figure 2G).
vicinity of (within 0.5 m), and often continuous with, This observation is consistent with our own and with
an ERES. The main difference between containers of previously published IF details (Stephens and Pep-
types I and II was that the former were embedded in perkok, 2002).
the ER cisterna, whereas the latter had protruded out A notable similarity between VSVG- and PC-con-
and were clearly segregated from the ER cisterna, al- taining carriers was that only a very few vesicles and
though always associated/connected with it by tubules. buds (which were devoid of cargo) were seen in the
Thus, type II structures probably represent carriers after vicinity of both containers, and that type I and type II
protrusion from the ER (see below). Remarkably, the carriers appeared to be connected with the ER (33 VSVG
type I and II PC saccular carriers were devoid of COPII carriers and 27 PC carriers were analyzed; see Fig-
labeling, which, in contrast, was intense on the adjacent ures 3B–3H).
ERES (Figure 1F; see also Figure 1B and Discussion). To verify the observation that many carriers were con-
Very few bona fide buds were present in these regions. nected to the ER, stereo-tilting analysis or electron to-
Type III: distensions (300 nm in length) embedded in mography were used (Figures 3I and 3J), the latter of
thin (50–70 nm) tubules devoid of ribosomes, which were which provides a 3D resolution on the order of 5–7 nm.
usually radially oriented. These structures were uncom- This eliminates most of the ambiguities of 3D recon-
mon, and were visible only in tangential thick (or serial) structions from serial sections. Nine VSVG containers
EM sections (Figures 1J and 1K). As shown later, they were immunoperoxidase labeled and subjected to elec-
appear to be carriers caught during translocation toward tron tomography (e.g., Figures 3I and 3J), and 33 VSVG
the Golgi. Type IV: larger and more complicated mem- containers and 13 PC containers (type II) were subjected
branes comprising several (two to four) saccules par- to double or single tilting and stereo pair analysis. All
tially stacked. These saccules are often associated with the type II carriers showed connectivity, and all the type
aggregates of oval and elongated profiles and with the IV carriers showed association, with the ER (Figures
ER (Figures 1L and 1M). The same four types of PC 3D and 3G). In these images, we also noted that the
containers were visible at steady state both in HFs and structures appearing as buds in single sections were
CEFs (unpublished observations). revealed in the 3D reconstructions of the ERESs to result
Next, VSVG-containing carriers were examined in HFs from oblique sections of tubules. Bona fide buds were
or COS7, RBL, or NRK cells, which were infected with few. Round (potentially vesicular) profiles (see Experi-
045VSV and left to accumulate VSVG in the ER at the mental Procedures for definition) were also analyzed
restrictive temperature (40C) for 3 hr. Cells were then
by tomography. Out of 174 round profiles analyzed in
shifted to the permissive temperature (32C) to allow
random virtual sections from four tomograms only 27
VSVG to exit the ER, and fixed at 0, 4, and 10 min after
were found to derive from vesicles, rather than fromrelease of the block. Although VSVG is a small diffusible
other structures. These data indicate that in routine 60molecule (Nehls et al., 2000) that can potentially enter
nm sections most round profiles correspond to struc-small transport vesicles, the overall structures of its car-
tures different from vesicles, and confirm that very fewriers were very similar to those just described for PC.
true vesicles are associated with ER exit domains. Addi-The differences were few, as follows. First, at time 0, in
tionally, to eliminate chemical fixation artifacts, samplesVSVG-expressing cells, there was a high background
were examined after rapid freezing-cryosubstitutionof reticular COPII fluorescence in IF images (Figures
(McIntosh, 2001). Because the low contrast of sections2A–2C), and in the corresponding EM images, COPII was
hampered recognition of carriers in thick sections, ultra-present not only on ERESs, but also over ER domains
thin (25–30 nm) serial sections were used instead of(Figure 2D). This diffuse COPII labeling was absent in
electron tomography (Figure 3K). In these samples,PC-secreting cells (see above) and might be due to
which cannot be immunolabeled, it was possible to un-binding of Sec23 to the cytosolic tail of VSVG (Aridor et
ambiguously recognize only type II carriers. These carri-al., 1998), which at this time is distributed throughout
ers were not substantially different from type II carriersthe ER. Indeed, 4 min after release of the folding block,
seen in fixed and immunostained cells (irregular sac-when VSVG had begun to concentrate in spots that
cules in continuity with the ER), except that they con-partially overlapped with the COPII-labeled ERESs (Fig-
tained some pores and exhibited a more “blebby” sur-ures 2H, 2I, and 2K; see Figure 2M for quantification),
the COPII background disappeared as the Sec23/31 face (compare Figure 3L with Figure 3F).
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Figure 2. Initial Stages of VSVG Exit from the ER
HFs (A–D) and COS7 (E–K) cells were infected with 045VSV, placed at 40C for 3 hr to accumulate VSVG in the ER (HFs were grown in the
presence of 10% FCS to inhibit the synthesis of PC), shifted back to 32C, fixed 0 (A–D) or 4 (E–K) min after the release of the temperature
block, and prepared for IF or IEM.
(A–C) Reticular pattern of VSVG ([B and C], red) and no colocalization with Sec31 ([A and C], green). Sec 31 reveals a significant background.
(D) Sec31 labeling of ER cisternae (asterisks) adjacent to an ERES (arrow).
(E and F) Emanation of tubules positive for VSVG (E) and Sec31 (F) from the ER 4 min after the release of the temperature block.
(G) Three-dimensional representation of COPI localization by immunoperoxidase, in the presence of 12% gelatin to prevent diffusion of the
DAB precipitate. Analogous results were obtained by nanogold labeling.
(H–K) Concentration of total VSVG ([I]; red, detection with anti-cytosolic domain antibodies), folded VSVG ([K]; blue, detection with I-14
antibodies; Lefrancois and Lyles, 1983), and ERESs ([J]; green, labeled with anti-Sec23). Both unfolded and folded VSVG are concentrated
at ERESs. Diffuse VSVG staining is barely detectable only for the unfolded form.
(L) Colocalization of PC, VSVG, COPII (Sec23), and COPI at various times after release of the exit block. The quantification is from confocal
sections, according to Mironov et al. (2001). Bars are standard errors from the quantification of 20 cells in each case.
(M) VSVG concentration (linear density) at ER exit domains at various times after release of the exit block. Exit domains include both the
ERES and the forming saccular carrier and are defined as described by Klumperman et al. (1998). The quantification is from cryosections
labeled with immunogold and from epon sections labeled by nanogold (then gold enhanced) at the preembedding step. The linear density of
gold particles at exit domains was normalized to the linear density of gold particles on ER membranes. Bars are standard errors from the
quantification of 20 cells in each case. At times 0 and 20 min, the quantification was performed only on cryosections.
The scale bars represent 7.5 m (A–C), 240 nm (D), 300 nm (E and F), and 2.5 m (G–J).
Correlative Video/Light Electron Microscopy at 40C for 12 hr (to accumulate VSVG in the ER), and
then shifted to 32C. At 40C, VSVG-FP fluorescenceShows that the Four Carrier Types Correspond
to Successive Maturation Stages showed an ER-like distribution, as expected (not
shown). Several seconds after the release of the 40CCarriers were next examined by both correlative video/
light and correlative light electron microscopy (CVEM temperature block, the motility of the ER mesh in-
creased, and the fluorescence gradually concentratedand CLEM, respectively) to associate the dynamics of
each carrier directly with its ultrastructure. HFs and (2- to 3-fold) into individual spots of less than 1 m in
size. Later, these spots became brighter (5- to 8-foldCOS7 cells were transfected with VSVG-FP, incubated
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Figure 3. Structure of VSVG-Containing Car-
riers
COS7 (A, B, and I–L) and RBL (C–H) cells were
treated as described in the legend to Figure
2, fixed 10 min after the release of the ER exit
block, and prepared for IF or for peroxidase
IEM. After IEM labeling, serial sections were
prepared and 3D reconstruction and surface
rendering were performed.
(A) Concentration of folded VSVG in the pe-
ripheral spots (red) is offset from Sec31-posi-
tive spots (green). The arrow shows the
VSVG-positive tubule.
(B) A type I carrier (white asterisk) widely con-
nected (arrows) to the ER (black asterisks) in
the vicinity of an ERES (arrowheads).
(C) Representative serial section of a type II
carrier. The arrow shows the EGC positive
for VSVG.
(D) Surface rendering (derived from [G]) of a
type IV carrier (red) in close vicinity to an
ERES (yellow) and the ER (white).
(E and F) Surface rendering (derived from [C])
of a type II carrier (red) in close vicinity to an
ERES (yellow in [E], omitted in [F]) and the
ER (white).
(G) Type IV carrier with three saccular do-
mains filled with VSVG (DAB precipitate) in
close vicinity to an ERES (arrow) and the
ER (asterisks).
(H) Type III carriers appearing on a 200 nm
tangential section as varicosities (arrows)
along a thin radial tubule.
(I and J) Thick (250 nm) sections of carriers
labeled for VSVG (DAB precipitate) were cut, prepared for electron tomography, and virtual 2–3 nm slices (e.g., in [I]) were extracted from the
tomograms. Three-dimensional reconstruction and surface rendering of the VSVG-containing carrier (red) and the ER (yellow) were performed
(see [J]). The arrows in [I] and [J] show the sites of connection between the ER and the VSVG container.
(K) Serial ultrathin (30 nm) sections of a carrier from rapid freezing-cryosubstitution were cut and used to form a 3D reconstruction of the
image (see [L]). The black arrows indicate the ER and its connection to the ERES (white arrow).
(L) Saccular container (red) with a blebby surface connected to the ER (green). Six containers were examined by this approach, and they
were all connected to the ER.
The scale bars represent 1.5 m (A), 150 nm (B, C, I, and K), 200 nm (G), and 150 nm (H).
brighter than ER loops), and began to move centripetally 4G), structures which were very similar to type III carri-
ers. Finally, slow translocating carriers exhibited thealong ER loops in an apparently microtubule-dependent
manner (see Supplemental Movie 1 at http://www. complex structure classified as type IV: an aggregate
of flattened tubular networks and saccules (seeminglydevelopmentalcell.com/cgi/content/full/5/4/583/DC1).
Interestingly, just before moving, most (95%) of these stacked, albeit in an irregular fashion), surrounded by
round profiles (Figure 4D).large, bright objects emanated a thin and less intensely
labeled tubule toward the cell center (Figure 4A). During CLEM was also used for the ultrastructural character-
ization of the carriers as a function of their COPII/COPItheir centripetal movement they differentiated in either
of two types of carriers. One was found more often near labeling. It is known that early forming carriers contain
COPII; later, carriers acquire COPI (i.e., label for boththe Golgi and was larger and moved slowly, in a stop-
and-go (presumably microtubule-mediated) fashion COPII and COPI), and, finally, they lose COPII (Scales
et al., 1997). Cells were fixed 10 min after release of the(slow translocating carrier). The other type (mostly pe-
ripheral) was smaller, less luminous, and moved more temperature block, and therefore, as described above,
contained a mixture of carriers of all “ages.” The mor-swiftly and directly toward the Golgi (fast translocat-
ing carrier). phology of COPII-labeled (thus, presumably recently
formed) carriers is exemplified in Figure 4K. Their ultra-The cells were then fixed and individual carriers were
subjected to 3D reconstruction by correlative micros- structure appeared to fall into the type I grouping. Carri-
ers containing both COPII and COPI (Figure 4L) were ofcopy (21 carriers). This showed that carriers just after
formation (Figures 4B, 4C, 4H, and 4I) belong to the type the structural type II, whereas containers labeling only
for COPI exhibited the type IV organization (Figure 4M).I class. Carriers that had already produced a centripetal
tubule, which appears to be associated with the begin- In summary, these results suggest that type I VSVG
containers are COPII positive and form through cargoning of movement (Figure 4E), exhibited a type II struc-
ture (a 3D reconstruction is shown in Figure 4J). Fast concentration within the lumen of an ER cisterna and
the initial protrusion of this domain; type II containerstranslocating carriers appeared as varicosities embed-
ded in straight, radially oriented tubules (Figures 4F and are COPII- and COPI-positive and develop from those
Developmental Cell
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Figure 4. The Carrier Life Cycle by CVEM and
CLEM Analyses
COS7 cells were transfected with VSVG-FP,
placed in glass-bottomed microwell dishes
with coordinated grids, kept for 12 hr at 40C
to accumulate VSVG-FP in the ER, shifted to
32C to release VSVG from the ER, and then
examined by time-lapse analysis under the
laser-scanning confocal microscope (A) and
prepared for CVEM (B–J). COS7 cells were
also grown on dishes with coordinated grids
(K–M), treated as described in the legend to
Figure 3, fixed, and prepared for CLEM. Next,
VSVG, COPII, and COPI were visualized with
IF, and COPII-, COPII/COPI-, and COPI-posi-
tive carriers were selected after Z stacking
under the laser-scanning confocal micro-
scope, and cells were embedded in epon and
serially cut, with their subsequent identifica-
tion at the EM level.
(A) Inverted video frames showing the emana-
tion of thin VSVG-FP-positive tubules from
the VSVG-FP-positive spots on their way to-
ward the Golgi.
(B and C) Representative serial sections of
type I carriers, which were subjected to 3D
reconstruction ([I] and [H], respectively) after
their analysis by videomicroscopy. Six other
carriers examined at a similar stage in their
life cycle all showed a similar ultrastructure.
(D–G) Representative serial sections of a
slowly moving, type IV carrier (D); a type II
carrier just before its centripetal movement
([E]; three such carriers were examined); and
two quickly moving, type III carriers detected
under the nucleus (F and G). At the IF level,
the last of these (type III) appear as bright
varicosities along the less bright fluorescent
tubule. Two other carriers of type III exhibiting
the same type of mobility were examined.
(H–J) Three-dimensional reconstruction and surface rendering of ER-to-Golgi containers ([H], from [C]; [I], from [B]; [J], from [E]) (red) and ER
in white (H and I) or green (J). An ERES is in yellow (J).
(K–M) Examples of COPII-positive ([K], type I), COPII/COPI-positive ([L], type II), and COPI-positive ([M], type IV) carriers identified by CLEM.
The scale bars represent 4 m (A), 140 nm (B, D–F, and K–M), and 100 nm (C and G).
of type I through further protrusion and segregation of the Figures 1 and 2, VSVG partially colocalized with COPII
(Figure 5I), whereas PC did not (Figure 5J). PC and VSVGcargo domain from the parent ER cisterna. Both type III
(COPI- and COPII-negative) and type IV (COPI-positive) were in the same container, but within different domains
of this structure (Figure 5K). Later, in the brighter carrierscarriers appear to develop from those of type II, concom-
itant with the beginning of centripetal movement. seen 10 min after release, the degree of overlap between
PC and VSVG was higher by IF (Figures 5E–5H). Corre-
spondingly, by immuno-EM, VSVG and PC exhibited aPC and VSVG Exit from Different Domains
higher degree of colocalization at later times after re-of the Same ERESs
lease of the block (Figure 5L). Thus, PC and VSVG con-It has been reported recently that transfected PC and
centrate in different domains of the same ERESs, butVSVG exit the ER at separate ERESs in Vero and HeLa
later converge into the same carrier domain positive forcells (Stephens and Pepperkok, 2002). To examine the
COPI (Figure 5M).relationship between PC and VSVG ERESs, HFs were
infected with 045VSV and then both PC and VSVG were
blocked and accumulated in the ER. Four and 10 min The Formation of ER-to-Golgi Carriers Does Not
Involve Vesicle Budding/Fusion but Dependsafter release of the block, cells were fixed (see Mironov
et al., 2001) and carriers containing PC and VSVG were on the Function of COPII
Our above observations are difficult to reconcile withanalyzed by both IF and immuno-EM (IEM; Figure 5).
The initial concentration step of PC and VSVG (at 4 min the current idea that carriers form by budding, followed
by homotypic fusion of vesicles. We thus examinedafter release) appeared to take place either at distinct
ERESs or, more often, in adjoining but nonoverlapping whether our finding that vesicles near ERESs are few
and devoid of cargo might be due to technical limita-regions of the same ERES (by IF, PC and VSVG spots
were very close but nearly completely separated; see tions. First, additional immunolabeling techniques were
used to verify whether limited access of the antibodiesFigures 5A–5D). As expected from the observations in
ER-to-Golgi Transport
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Figure 5. PC and VSVG Are Concentrated in
Different Domains of the ER but Move to the
Golgi by the Same Transport System
HFs were stimulated to synthesize PC by
adding 1% calf serum, then infected with
045VSV and incubated at 40C for 3 hr in the
absence of ascorbic acid to accumulate both
PC and VSVG in the ER. Next, cells were
shifted to 32C and 50 g/ml of ascorbic acid
was added back to the medium to release
both the temperature and hydroxylation
blocks. The HFs were fixed at 0 (not shown),
4 (A–D and I–K), or 10 (E–H, L, and M) min after
the temperature shift. Cells were prepared for
IF or IEM.
(A–D) Initial concentration (4 min) of folded
VSVG (red) and folded PC (blue) in different
ER domains adjacent to an ERES (Sec23,
green).
(E–H) Coalescence (10 min) of folded VSVG
(red) and folded PC (blue) in the carriers in
the vicinity of an ERES (Sec23, green).
(I) Colocalization of VSVG (10 nm particles)
and COPII (15 nm particles) in the same do-
mains of the ER (presumably exit domains) 4
min after release of the block.
(J) Lack of precise colocalization between PC
(15 nm particles) and COPII (10 nm particles)
4 min after the release of the block.
(K) Concentration of VSVG (10 nm particles)
and PC (15 nm particles) in different domains
of the ERES 4 min after the release of the
block.
(L) Colocalization of VSVG (10 nm particles)
and PC (15 nm particles) in the same carriers
in the vicinity of the Golgi 10 min after release
of the block.
(M) Colocalization of VSVG (10 nm particles)
and COPI (15 nm particles) in the same carri-
ers 10 min after the release of the block.
er, endoplasmic reticulum; g, Golgi complex;
m, mitochondria; n, nucleus.
The scale bars represent 0.3 m (A–D and
E–H), 150 nm (I, K, and M), and 100 nm (J
and L).
could be a crucial barrier for detection of a luminal anti- the vicinity of ERESs, which were instead mostly devoid
of ssHRP (Figures 6E and 6F). The ssHRP sacculesgen in vesicles. In addition to saponin, different deter-
gents (0.1% Triton X-100, Figure 6A; 0.2% Nonidet P-40, strongly resembled the PC and VSVG type I and type
II carriers described above, and most likely representnot shown) were used for membrane permeabilization
in preembedding experiments. Second, vesicles were ssHRP containers exiting the ER. In contrast, again, no
ssHRP was observed in vesicles. These data confirmexamined using an antibody against the cytosolic tail
of VSVG, and vesicles were discriminated from cross- that the small diffusible secretory proteins VSVG and
ssHRP are depleted in 60 nm vesicles and buds locatedsections of tubules by tilting analysis. In all cases, gold
particles were associated with saccules and tubules, near the ERESs.
Second, we sought to test whether our failure to ob-but not with vesicles and buds (Figures 6B and 6C).
Third, a radically different approach was used. Cells serve cargo-laden vesicles might be because such vesi-
cles are too transient to be detected by our experimentalwere transfected with secretory soluble horseradish
peroxidase (ssHRP), the detection of which is free from design. If this were the case, that is, if COPII-dependent
vesicles fuse immediately after formation to generate aall of the problems related to antibody access to epitope
(Connolly et al., 1994), fixed at steady state (ssHRP can- saccular container, they should accumulate (and hence
should become detectable) when fusion is inhibited;not be synchronized) 24 hr after transfection, and sub-
jected to the HRP reaction procedure (Connolly et al., therefore, clusters of vesicles, rather than saccular carri-
ers, should be observed. To test this possibility, mem-1994). In some cells, DAB precipitate formed a diffuse
staining within the ER, so only cells with low levels of brane fusion was blocked by inhibiting NSF or p97, two
proteins controlling cellular fusion events. Anti-NSF anti-ssHRP expression were chosen for observation (Figure
6D). ssHRP was localized in saccules (250–400 nm in bodies were used first, under conditions shown to be
effective in inhibiting membrane fusion (Fukunaga et al.,diameter) that were connected to the ER and located in
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Figure 6. VSVG Exit Does Not Involve 60 nm
Vesicles In Vivo but Depends on the COPII
Machinery
RBL (A) and COS7 (C–F) cells were treated
as described in the legend to Figure 3, or
COS7 cells (B) were infected and kept at 32C
for 2 hr. The cells were chemically fixed and
prepared for IEM (A–C), or transfected with
ssHRP, fixed 24 hr after transfection (at
steady state), and then processed for detec-
tion of ssHRP (Connolly et al., 1994; D–F).
(A) Permeabilization of cells with 0.1% Triton
X-100 neither changes the structure of the
VSVG containers (thin arrow) or the ER (thick
arrows), nor induces the appearance of label-
ing in round profiles (arrowheads).
(B and C) VSVG (visualized with the P5D4
monoclonal antibodies against the VSVG cy-
tosolic domain) is concentrated in a saccular
domain (arrowhead), which is connected to
the ER (thick arrow in [C]), but is not present
in round profiles of ERESs (thin arrows). The
structure of the VSVG containers (in [B]) at
steady state is similar to that after cargo syn-
chronization.
(D–F) ssHRP is present in saccular carriers
(arrowheads) but not in profiles of ERESs
(arrow in [D]).
(G–J) VSVG (red) is concentrated in the pe-
ripheral Sec31-positive (green) spots in NSF
antibody-microinjected cells (detected by
Cy5; blue in [G]).
Microinjection with anti-NSF and anti-p97 an-
tibodies. BHK cells (G–N) were infected with
045VSV, and after accumulation of VSVG in
the ER (see legend to Figure 2) at 40C, they
were microinjected (at 40C) with the inhibi-
tory anti-NSF (G–J and K–M) or anti-p97 (N)
antibodies mixed with anti-mouse Fab frag-
ments conjugated with Cy5 (see Experimental
Procedures). After an additional 30 min incu-
bation at 40C, the cells were shifted to 32C
and fixed after 10 min. Injected cells were
found using CLEM (not shown). In mock-
injected cells (arrow in [I]), VSVG was also
found in the Golgi area. Cells were prepared
for IF or IEM (nanogold-enhanced, [K]; immu-
noperoxidase, [L–N]).
(K–N) Generation of type II (K, L, and N) and
type IV (M) carriers. VSVG exiting from the ER
concentrates in saccular domains (arrows) of
the ERESs. No accumulation of VSVG-
containing round profiles (arrowheads) was
seen.
(O) Microinjection of wild-type Sar1p does not interfere with the exit of PC (red) from the ER. The inset shows the FITC-dextran that was
injected together with Sar1p.
(P and Q) Microinjection of Sar1p-GDP inhibits the exit of PC (red) from the ER. The inset shows the FITC-dextran that was injected together
with Sar1p-GDP. The arrow shows a noninjected cell.
Microinjections with GDP-restricted Sar1p. HFs cells were microinjected with tagged versions (see Experimental Procedures) of either wild-
type Sar1p or GDP-restricted Sar1p at 40C. Thirty minutes after microinjection, the exit block was removed and the cells were examined by
immunofluorescence 10 min after the shift. A similar trial was performed on VSVG exit from the ER, with similar results.
The scale bars represent 100 nm (A), 140 nm (B and C), 120 nm (D), 60 nm (E and F), 5 m (G–J and O), 80 nm (K–N), and 10 m (P and Q).
1998). Because these antibodies are specific for ham- these spots were not clusters of vesicles; rather, they
were typical VSVG-positive type I, type II (Figures 6Kster, BHK cells were infected with 045VSV, incubated
at 40C to accumulate VSVG in the ER, microinjected and 6L), and type IV containers (Figure 6M). As a positive
control, round profiles with a diameter expected forwith the anti-NSF antibody at 40C, and then (after 10
or 30 min of additional incubation at 40C) shifted to the COPI vesicles increased 3-fold in number in the vicinity
of the Golgi complex, confirming that the anti-NSF anti-permissive temperature of 32C. Four minutes after the
shift, VSVG-positive spots were seen in the cell periph- body had inhibited vesicle fusion (not shown; see also
Mironov et al., 2001). Instead, vesicles in the vicinity ofery (not shown), and they grew larger over 10 min (Fig-
ures 6G–6J). Crucially, CLEM analysis revealed that ERESs remained scarce and did not contain VSVG, as
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determined by nanogold labeling with an antibody
against the cytosolic domain of VSVG (Figure 6K). Simi-
larly, the microinjection of an -SNAP dominant-nega-
tive mutant, which inhibits NSF-mediated fusion (Band
et al., 2001), or of an inhibitory anti-p97 antibody (Rabou-
ille et al., 1995) in COS7 cells, did not affect the exit of
VSVG from the ER and did not induce accumulation
of VSVG-positive vesicles under similar experimental
conditions (Figure 6N). Collectively, these data indicate
that the formation of large carriers exiting the ER does
not require the budding and fusion of small COPII ves-
icles.
Nevertheless, COPII is essential for export from the
ER of all the cargo molecules so far examined (Antonny
and Schekman, 2001). To test the role of COPII in the
formation of the large PC- and VSVG-containing carriers
from the ER, we microinjected Sar1p wild-type (Figure
6O) or a GDP-restricted form of Sar1p (Figures 6P and
6Q) that has previously been shown to inactivate the
COPII machinery (see Aridor et al., 2001). Because of
the low solubility of these proteins and the need to inject
them at high concentrations, we added a short hydro-
philic peptide to their N terminus (see Experimental Pro-
cedures). Cells were injected 30 min before releasing
the exit block, and examined 10 min after the release
of the block. The injected Sar1p-GDP mutant markedly
inhibited the exit of both PC- and VSVG-containing carri-
ers from the ER, whereas Sar1p wild-type was with-
out effect.
Discussion
This study describes the dynamics and structure of
forming and translocating ER-to-Golgi carriers based
on the use of CVEM and tomography. The formation of
carriers can be summarized as follows (see Figure 7):
their appearance begins with the concentration of cargo
within domains of the ER adjacent to ERESs (type I in
Figures 7A and 7B). Both the ERES and the VSVG (but
not the PC) cargo domains are coated with COPII. After
(or during) this initial concentration, the cargo-con-
taining domain protrudes from the ER as a large and Figure 7. Schematic Representation of ER-to-Golgi Carrier Types
relatively irregular saccule that remains continuous with Procollagen is drawn in brown thin lines; VSVG, in green dots; COPII,
in blue dashed line; and COPI, in red spheres.the ER (type II in Figures 7C and 7D). Next, the saccular
(A and B) Type I. Distended domains of the ER with concentratedcargo domain is further segregated from the ER, but
cargo are located close (from a few nm to 0.5 m) to an ERES andremains connected to it by short tubules. The cargo-
are likely to be containers fixed just in the process of appearing
containing sacculus then starts moving toward the cen- from the ER. ERESs (A and B) and VSVG carriers (B) are coated
ter of the cell, and develops into a translocating carrier with COPII, while PC carriers (A) are not. PC is excluded from ERESs,
of either type III (Figures 7E and 7F) or type IV (Figures whereas VSVG often partially penetrates them.
(C and D) Type II. Flattened and elongated (300 nm) saccules7G and 7H). For VSVG carriers, this transition is marked
protruding from, but still in continuity through tubules with, the ER.by the complete replacement of COPII with COPI (type
These develop from type I carriers after protrusion from the ER.IV) or by the loss of coat (type III). The type III and type
COPI is localized at the isthmus of the protruded carrier (D).
IV translocating carriers are quite different in terms of (E and F) Type III. Distensions (300 nm in length) embedded in
dynamics, morphology, and composition. Type IV carri- thin (50–70 nm) tubules devoid of ribosomes, which are usually
ers “wander” relatively slowly through the cytosol in a radially oriented. They appear to be carriers caught during transloca-
tion toward the Golgi.stop-and-go fashion, comprise two or more saccules
(G and H) Type IV. Larger and more complicated membranes com-(usually loosely stacked) and variable tubular compo-
prising several (two to four) saccules partially stacked and associ-nents, and label for COPI. Because they are larger than
ated with the ER. The association with the ER is represented with
the static type II containers, they may result from the a dashed line.
growth of type II saccules, or from the coalescence (I) Type I carriers containing both VSVG and PC in the same cell
of two or more of these. Instead, type III carriers are (HF). PC and VSVG do not share the same zone of the ER before exit.
(J) Development of the carriers as inferred from CVEM experiments.elongated distensions (about 400 nm long) that are not
coated with any COP and move quickly within radial
membranous tubules. To our knowledge, this kind of
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carrier has not been reported previously, possibly be- Sec22 and Bet1 (Klumperman et al., 1998; Chao et al.,
1999), but all of these proteins (COPII, Sec22, and Bet1)cause of its small size, low frequency, and rapid move-
ment. The mechanisms by which type II containers de- exhibit a rather stable location and do not exhibit signifi-
cant centripetal movement (Chao et al., 1999; Hammondvelop into type III or type IV translocating carriers are
unclear at this time, as is the difference in function, if and Glick, 2000). Instead, these permanently COPII-pos-
itive sites can become associated with cargo proteinany, between type III and type IV carriers. A scheme of
the evolution of ER-to-Golgi carriers is shown in Fig- (VSVG; Stephens et al., 2000) during a cargo concentra-
tion step, but they remain peripheral as cargo dissoci-ure 7J.
PC- and VSVG-containing carriers are altogether simi- ates from them and moves toward the Golgi. We envision
that a key role of the ERESs is to concentrate and storelar, but not identical, at all stages. One difference is
that during formation the saccules containing VSVG are proteins of the fusion machinery (e.g., SNAREs) through
binding to COPII. In addition, the ERESs might includecovered with COPII, whereas those containing PC are
not. Second, PC and VSVG do not appear to concentrate microtubule-docking and membrane-bending devices,
as well as ion pumps controlling the immediately adja-within the same regions of the forming containers at the
ERESs. Rather, they localize into separate but adjacent cent luminal environment. At each carrier departure, a
suitable complement of this accumulated machinerydomains of their container (Figure 7I). We hypothesize
that the reason for these divergences is that the mecha- might be incorporated into the outgoing carrier. Other
important roles of COPII at the exit domains might be,nisms for VSVG and PC recruitment and concentration
at ERESs are different. VSVG binds the COPII subunit in the case of some (probably many) secretory proteins
(such as VSVG), to act directly (or via adaptors; seeSec23/24 (Aridor et al., 2001) through its cytosolic tail.
It is therefore logical to presume that it is recruited to Antonny and Schekman, 2001) to recruit cargo proteins
into carriers, or to help bending the membrane of VSVGthe ERESs through such binding (see Aridor et al., 1998).
In contrast, as a soluble protein, PC does not bind di- carriers into a tubular-saccular shape for protrusion out
of the ER.rectly to COPII. In principle it is possible that PC binds
to a cargo receptor, for instance one of the p24 proteins, The observations in this study, which are based on a
set of high-resolution morphological techniques, speakwhich in turn binds to COPII through its cytosolic tail
(Antonny and Schekman, 2001). However, the absence strongly against the view that in vivo ER-to-Golgi carriers
form by budding and fusion of COPII vesicles. Instead,of COPII labeling on PC saccules at all times suggests
that this model is unlikely. How then can PC concentrate they indicate that these carriers form by progressive
extrusion of large ER domains specialized for export.at exit domains? A scheme could be envisaged that is
based on the ER exit mechanism determined for amy- They confirm, however, that the ER exit process abso-
lutely requires COPII for both PC and VSVG export. Howlase and chymotrypsinogen. These proteins have been
proposed to exit the ER by bulk flow (Martinez-Menar- can these findings be reconciled with the in vitro evi-
dence that COPII forms 60 nm vesicles (reviewed inguez et al., 1999), and to undergo condensation soon
after exit (Warren and Mellman, 1999). It has also been Antonny and Schekman, 2001)? Simply put, our hypoth-
esis is that in mammalian cells, the COPII machineryshown that under specific conditions the aggregation
of these enzymes can begin in the ER itself (Tooze et uses its fundamental properties of bending membranes
(Aridor et al., 2001) and sorting proteins (Aridor et al.,al., 2001). We hypothesize that a similar mechanism
could apply to the formation of PC carriers; namely, that 1998) to recruit cargo and machinery proteins into highly
curved membrane regions (the ERES tubules and thea first level of PC aggregation might begin in the ER,
and that the aggregates themselves might provide a tubular-saccular carriers), rather than to form vesicles.
However, the situation might be different in yeast, wheremechanism for protrusion, analogous to the case of
secretory granules (Arvan and Castle, 1998). This con- the smaller size and different environmental conditions
might favor a different organization.densation of PC in the ER may be favored by the creation
of a suitable local physical environment, such as low An in vivo analysis of the formation of ER-to-Golgi
carriers performed by Bannykh et al. (1996) provides apH, at ERESs (see Warren and Mellman, 1999). Some
experimental evidence in support of this possibility ex- different interpretation of the structure of these carriers,
and a more recent study (Horstmann et al., 2002) hasists, as a vacuolar ATPase proton pump has been shown
to be present in pre-Golgi carriers, where it is probably reported that carriers formed at 15C appear as clusters
of vesicles, rather than saccules. We believe the latterrecruited to by COPII. Thus, in the case of PC export
from the ER, one role of COPII would be to recruit ion to be an effect of the 15C block, during which carriers
grow enormously and present a very prominent convo-or proton pumps (as suggested by Ying et al., 2000) to
ERESs, in addition to the SNAREs and other protein luted tubular component (which could appear vesicular
in thin sections). No such structures are seen when carri-machineries needed for later trafficking events (see
below). ers form at the physiological temperatures used in our
study. Further, Horstmann et al. (2002) have reportedWhat is the precise nature and function(s) of the ER-
ESs? There are several lines of evidence indicating that that carriers at 15C are not in continuity with the ER.
In our view, the discrepancies between these and ourERESs participate in the formation of the cargo contain-
ers, but are not themselves containers that undergo observations can be explained by the fact that these
authors did not use tomography techniques, withoutcentralization and deliver cargo to the Golgi. One is that
they obviously do not contain significant amounts of which it is very difficult to detect continuities or to distin-
guish buds and vesicles from tubules.cargo (PC is completely and VSVG partially excluded;
see Figures 1 and 2). Second, as reported by others, In summary, we find that in living mammalian cells,
both PC- and VSVG-containing carriers arise from theERESs contain both COPII and IC SNAREs such as
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